Vira Shield 6+L5 HBThis page contains information on Vira Shield 6+L5 HB for veterinary use.
The information provided typically includes the following:
- Vira Shield 6+L5 HB Indications
- Warnings and cautions for Vira Shield 6+L5 HB
- Direction and dosage information for Vira Shield 6+L5 HB
Vira Shield 6+L5 HBThis treatment applies to the following species:
Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine
Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin
For Use In Animals Only
Vira Shield 6+L5 HB Indications
This product has been shown to be effective for the vaccination of healthy cows against disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae, and pomona. The duration of immunity against BVD Type 2 is at least 11 months and L. hardjo-bovis is at least 12 months. The duration of immunity for the remaining antigens in this product has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.
This product has been shown to be effective against hardjo bovis kidney colonization, urinary shedding and reproductive tract infection. Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo bovis) have been shown to clear renal infections within 8 weeks of exposure. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. This product is safe for use in pregnant cows and heifers.
ADJUVANT: Xtend™ SP.
Directions For Use
Shake well before using. Administer 5 mL subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate in 4 to 5 weeks. Vaccinate dairy cows at dry-off. Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. The presence of maternal antibody is known to interfere with the development of active immunity in calves and additional boosters will be required in most young animals. For advice on revaccination frequency, in general or in the face of maternal antibody, consultation with a veterinarian is recommended.
PrecautionsStore out of direct sunlight at 2° to 8°C (35° to 46°F). DO NOT FREEZE. Use entire contents when first opened. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.
Elanco US, Inc., Fort Dodge, IA 50501 USA; 1-800-428-4441
Vira Shield, Xtend, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
Distributed by ELANCO US, INC.
2500 INNOVATION WAY, GREENFIELD, IN, 46140
Copyright © 2022 Animalytix LLC. Updated: 2021-11-29